how does glutathione s-transferase cause drug resistance in cancer cells

how does glutathione s-transferase cause drug resistance in cancer cells Unveiling the Role of Protein Breast Resistance: Insights into the Signaling Pathways and Therapeutic Implications Frontiers | Modulation of redox

Name: how does glutathione s-transferase cause drug resistance in cancer cells Unveiling the Role of Protein Breast Resistance: Insights into the Signaling Pathways and Therapeutic Implications Frontiers | Modulation of redox
Brand: wiensworld.de
SKU: 82365844102
Price: 27.14 USD
Availability: InStock
Rating: 4.4212 (24 reviews)

Frontiers Modulation of redox homeostasis: A strategy to overcome cancer drug resistance Overexpression of Glutathione S Transferases in Human Diseases: Drug Targets and Therapeutic Implications Cancer drug resistance: an evolving paradigm Nature Reviews Cancer Glutathione S transferase Theta 2 causes drug resistance by inhibiting arsenic trioxide induced ferroptosis in pancreatic ductal adenocarcinoma ScienceDirect

SKU: 82365844102 · From wiensworld.de

4.4

USD27.14 USD74.14

Pay in 4 interest-free payments of $6.79 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Jul 31 - Aug 5

Description

Using advanced liposomal delivery, this formula helps protect active ingredients and improve bioavailability compared to standard supplements

While distinct from glutathione, these pathways work together

A study found the safety and effectiveness of adding EGCG to GA in patients with relapsingremitting MS

demonstrated in patients with advanced colorectal cancer treated by either anti-EGFR inhibition or without, the expression of autophagy proteins Beclin-1 and LC3 were not only associated with advanced colorectal cancer, but those with higher expression of these proteins experienced worse objective response rates, and shorter progression free survival